Literature DB >> 6232729

The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers.

J J Belch, B M McArdle, P Burns, G D Lowe, C D Forbes.   

Abstract

There is an increased frequency of arterial thrombosis in cigarette smokers. The changes in blood coagulation seen in these subjects have been studied by many workers but results have not always been in agreement. We wished to study the effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in ten habitual smokers, and to compare these results with non-smoking controls. Results show that the smoking group had higher plasma fibrinogen (p less than 0.04), lower plasminogen (p less than 0.02) and plasminogen activator (p less than 0.05), and higher plasma viscosity (p less than 0.003). The changes seen in cigarette smokers after smoking three cigarettes were an increase in the rate of platelet aggregation to ADP (p less than 0.02), an increase in alpha 2M, (p less than 0.02), and factor VIII RAG (p less than 0.05). Plasma viscosity was decreased (p less than 0.02) as was red cell deformability (p less than 0.02). We confirm an increased tendency to hypercoagulability in smokers compared to controls which becomes more pronounced immediately after smoking three cigarettes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232729

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

1.  [Wound healing complications in smokers, non-smokers and after abstinence from smoking].

Authors:  O Goertz; N Kapalschinski; T Skorzinski; J Kolbenschlag; A Daigeler; T Hirsch; H H Homann; T Muehlberger
Journal:  Chirurg       Date:  2012-07       Impact factor: 0.955

Review 2.  Smoking, the oral contraceptive pill, and Crohn's disease.

Authors:  A J Wakefield; A M Sawyerr; M Hudson; A P Dhillon; R E Pounder
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

3.  Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.

Authors:  A L Herrick; K Illingworth; A Blann; C R Hay; S Hollis; M I Jayson
Journal:  Ann Rheum Dis       Date:  1996-02       Impact factor: 19.103

4.  Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors.

Authors:  G Ranieri; V Filitti; A Andriani; M V Bonfantino; G Lamontanara; A Cavallo; M Milani; R De Cesaris
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

5.  Haemorrheological abnormalities in unstable angina pectoris: a relation independent of risk factor profile and angiographic severity.

Authors:  F J Neumann; H Tillmanns; P Roebruck; R Zimmermann; H M Haupt; W Kübler
Journal:  Br Heart J       Date:  1989-12

6.  Platelet changes after a saturated fat meal and their prevention by Dazmegrel, a thromboxane synthetase inhibitor.

Authors:  J J Belch; A R Saniabadi; K McLaughlin; C D Forbes
Journal:  Lipids       Date:  1987-03       Impact factor: 1.880

7.  Epidemiological characteristics of platelet aggregability.

Authors:  T W Meade; M V Vickers; S G Thompson; Y Stirling; A P Haines; G J Miller
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-09

8.  Cigarette smoking increases white blood cell aggregation in whole blood.

Authors:  A B Bridges; A Hill; J J Belch
Journal:  J R Soc Med       Date:  1993-03       Impact factor: 18.000

9.  Eicosapentaenoic acid/arachidonic acid ratio and smoking status in elderly patients with type 2 diabetes mellitus.

Authors:  Kenta Okada; Kazuhiko Kotani; Hiroaki Yagyu; Shun Ishibashi
Journal:  Diabetol Metab Syndr       Date:  2014-08-13       Impact factor: 3.320

10.  Global screening of human cord blood proteomes for biomarkers of toxic exposure and effect.

Authors:  David R Colquhoun; Lynn R Goldman; Robert N Cole; Marjan Gucek; Malini Mansharamani; Frank R Witter; Benjamin J Apelberg; Rolf U Halden
Journal:  Environ Health Perspect       Date:  2008-12-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.